Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Adocia, Advaccine, Asieris, Beigene, Brii, Curevac, Escugen, H. Lundbeck, Hoth, Inovio, Kintor, Merck, Nrx, Otsuka, Regeneron, Ridgeback, Roche, Sorrento, Tonghua Dongbao.